Filing Details
- Accession Number:
- 0000950170-25-023253
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-02-19 16:35:58
- Reporting Period:
- 2025-02-14
- Filing Date:
- 2025-02-19
- Accepted Time:
- 2025-02-19 16:35:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1774857 | Aardvark Therapeutics Inc. | AARD | Pharmaceutical Preparations (2834) | 821606367 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1940120 | Tien-Li Lee | 4370 La Jolla Village Drive, Suite 1050 San Diego CA 92122 | Chief Executive Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-02-14 | 41,303 | $0.00 | 1,479,633 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2025-02-14 | 16,542 | $16.00 | 1,496,175 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A Convertible Preferred Stock | Disposition | 2025-02-14 | 350,002 | $0.00 | 41,303 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,474,028 | Indirect | By Spouse |
Footnotes
- The Series A Convertible Preferred Stock of Aardvark Therapeutics, Inc. (the "Issuer") automatically converted on an 8.474-for-1 basis into shares of the Issuer's common stock ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock. The Series A Convertible Preferred Stock had no expiration date.
Billionaire Hedge Funds
